Delivery Order SPE2DB25D3008-SPE2DB25FRBTF
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,832.90 Firm Fixed Price Delivery Order is for the supply of ADCIRCA 20 MG TABLET 60S, a pharmaceutical product, with a performance period through May 7, 2025. The contract is not set aside and represents open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award is a delivery order placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADCIRCA 20 MG TABLET 60S, a medical product, with a ceiling value of $13,983.38 and a completion date of March 6, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,202.50 firm-fixed-price delivery order is for the supply of ADCIRCA 20 MG TABLET 60S, a pharmaceutical product. The contract is not set aside and has an ultimate completion date of May 9, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,192.71 firm fixed-price delivery order contract, which runs through March 2025, is for the supply of ADCIRCA 20 MG TABLET 60S, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
- This federal contract award, valued at $5,128.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ADCIRCA 20 MG TABLET 60S, a medical product, with an ultimate completion date of April 15, 2025. The contract type is Delivery Order with a Firm Fixed Price pricing structure. This award is not associated with a set-aside designation. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,699.76 firm-fixed-price delivery order is for the supply of ADCIRCA 20 MG TABLET 60S, a medication used to treat pulmonary arterial hypertension. The contract has an ultimate completion date of October 23, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $6,145.04 firm-fixed-price delivery order is for 4567157014 - ADCIRCA 20 MG TABLET 60S, with a completion date of February 5, 2025. The contract is not designated with a set-aside requirement. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly...
- This is a $26,360.53 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ADCIRCA 20 MG TABLET 60S, a medication, with a period of performance through July 11, 2025. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global...
- This federal contract award, valued at $5,310.01, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,491.22 firm fixed-price delivery order is for ADCIRCA 20 MG TABLET 60S, a pharmaceutical product. The contract has no set-aside designation, indicating open competition. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRBTFDelivery Order
This federal contract award, with ID SPE2DB25D3008|SPE2DB25FRBTF, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,588.83 firm fixed-price delivery order is for the supply of ADCIRCA 20 MG TABLET 60S, a medication, with an ultimate completion date of April 9, 2025. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract award described is not set-aside and represents an open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.6k | 4/8/25 |